Orgenesis Inc. Faces Delisting Notice

Ticker: ORGS · Form: 8-K · Filed: Oct 17, 2024 · CIK: 1460602

Orgenesis INC. 8-K Filing Summary
FieldDetail
CompanyOrgenesis INC. (ORGS)
Form Type8-K
Filed DateOct 17, 2024
Risk Levelhigh
Pages2
Reading Time3 min
Key Dollar Amounts$1.00, $2.5 million
Sentimentbearish

Sentiment: bearish

Topics: delisting, listing-standards, regulatory-filing

TL;DR

Orgenesis Inc. got a notice about possibly getting delisted. Big trouble ahead?

AI Summary

Orgenesis Inc. filed an 8-K on October 17, 2024, to report a notice of delisting or failure to satisfy continued listing rules. The company, incorporated in Nevada, is involved in the pharmaceutical preparations industry.

Why It Matters

This filing indicates potential issues with Orgenesis Inc.'s continued listing on an exchange, which could impact its stock trading and investor confidence.

Risk Assessment

Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's ability to remain publicly traded.

Key Players & Entities

FAQ

What specific listing rule or standard has Orgenesis Inc. failed to satisfy?

The filing does not specify the exact rule or standard that Orgenesis Inc. has failed to satisfy, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.

What is the date of the earliest event reported in this 8-K filing?

The date of the earliest event reported is October 17, 2024.

In which state is Orgenesis Inc. incorporated?

Orgenesis Inc. is incorporated in Nevada.

What is the Commission File Number for Orgenesis Inc.?

The Commission File Number for Orgenesis Inc. is 001-38416.

What is the business address of Orgenesis Inc.?

The business address of Orgenesis Inc. is 20271 Goldenrod Lane, Germantown, MD 20876.

Filing Stats: 668 words · 3 min read · ~2 pages · Grade level 11.1 · Accepted 2024-10-17 17:09:35

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ORGENESIS INC. Date: October 17, 2024 By: /s/ Victor Miller Victor Miller Chief Financial Officer, Treasurer and Secretary

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing